Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Banvit Bandirma Vitaminli Yemnayii AS's accounts receivables for the quarter that ended in Jun. 2026 was ₺2,252 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Banvit Bandirma Vitaminli Yemnayii AS's Days Sales Outstanding for the quarter that ended in Jun. 2026 was 23.56.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Banvit Bandirma Vitaminli Yemnayii AS's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was ₺-36.49.
Banvit Bandirma Vitaminli Yemnayii AS Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Banvit Bandirma Vitaminli Yemnayii AS's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Banvit Bandirma Vitaminli Yemnayii AS's accounts receivable are only considered to be worth 75% of book value:
Banvit Bandirma Vitaminli Yemnayii AS's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Banvit Bandirma Vitaminli Yemnayii AS Accounts Receivable Related Terms
Banvit Bandirma Vitaminli Yemnayii AS Accounts Receivable Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Banvit Bandirma Vitaminli Yemnayii AS Accounts Receivable Chart
What does a Accounts Receivable of ₺2,252 Mil mean?
Banvit Bandirma Vitaminli Yemnayii AS (IST:BANVT) has a Accounts Receivable of ₺2,252 Mil as of Jun. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Banvit Bandirma Vitaminli Yemnayii AS and its competitors.
Is Banvit Bandirma Vitaminli Yemnayii AS's Accounts Receivable too high?
Banvit Bandirma Vitaminli Yemnayii AS's current Accounts Receivable is ₺2,252 Mil. Overall, Banvit Bandirma Vitaminli Yemnayii AS has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Banvit Bandirma Vitaminli Yemnayii AS's Accounts Receivable compare to KHC and GIS?
Banvit Bandirma Vitaminli Yemnayii AS's Accounts Receivable of ₺2,252 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Consumer Packaged Goods company?
A good Accounts Receivable depends on the Consumer Packaged Goods industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Banvit Bandirma Vitaminli Yemnayii AS and its competitors. Banvit Bandirma Vitaminli Yemnayii AS's current Accounts Receivable is ₺2,252 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Banvit Bandirma Vitaminli Yemnayii AS stock overvalued right now?
Based on GuruFocus' analysis, Banvit Bandirma Vitaminli Yemnayii AS (IST:BANVT) is currently considered Modestly Undervalued. The stock's GF Value™ is ₺172.03, compared to a current price of ₺151.80 — trading 11.8% below its estimated fair value. The current Accounts Receivable is ₺2,252 Mil. Banvit Bandirma Vitaminli Yemnayii AS's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Banvit Bandirma Vitaminli Yemnayii AS (IST:BANVT), the current Accounts Receivable is ₺2,252 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Banvit Bandirma Vitaminli Yemnayii AS (IST:BANVT) Overvalued in 2026?
Based on GuruFocus' analysis, Banvit Bandirma Vitaminli Yemnayii AS stock appears to be undervalued.
The current stock price of ₺151.80 is trading 11.8% below its estimated GF Value™ of ₺172.03.
GuruFocus considers Banvit Bandirma Vitaminli Yemnayii AS to be Modestly Undervalued.
Key valuation signals for IST:BANVT:
Accounts Receivable: ₺2,252 Mil
GF Value™: ₺172.03 vs. price of ₺151.80 (11.8% below fair value)
No single metric tells the full story. See the IST:BANVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Banvit Bandirma Vitaminli Yem Sanayii AS is engaged in the production, processing, sales, and marketing of feed, breeder eggs, day-old broiler chicks, live broilers, broiler meat, and further processed products.
60GF Score
Get the complete analysis for IST:BANVT
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:BANVT has been successfully added to your 
